Skip to content
HowShorted

Medicines Company (The) short interest in 2018

In 2018, Medicines Company (The)'s disclosed short interest ran from 26.96% of shares outstanding on 12 Jan 2018 to 28.51% on 31 Dec 2018, a change of +1.55 percentage points. The year's high was 28.51% on 31 Dec 2018 and its low 22.32% on 31 Oct 2018, averaging 25.66% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 32.62 days on 31 May 2018. Full history: Medicines Company (The).

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019

Aggregate net short position time series for Medicines Company (The) in 2018

2018 in figures

Start of year
26.96% (12 Jan 2018)
End of year
28.51% (31 Dec 2018)
Change
+1.55 pp
High
28.51% (31 Dec 2018)
Low
22.32% (31 Oct 2018)
Average
25.66%
Highest days to cover
32.62 (31 May 2018)
SEC filings marked
8

Every report in 2018

Medicines Company (The) short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 201826.96%18.69
31 Jan 201826.40%7.69
15 Feb 201826.65%16.31
28 Feb 201827.92%14.54results (8-K)
15 Mar 201826.81%11.9110-K filed
29 Mar 201827.24%17.26
13 Apr 201827.45%22.63
30 Apr 201826.47%27.95results (8-K)
15 May 201826.06%25.1410-Q filed
31 May 201828.22%32.62
15 Jun 201826.52%22.03
29 Jun 201826.28%23.71
13 Jul 201826.01%19.05
31 Jul 201824.44%29.09
15 Aug 201824.27%24.92results (8-K), 10-Q filed
31 Aug 201823.77%29.41
14 Sep 201824.68%19.35
28 Sep 201824.13%21.18
15 Oct 201823.80%16.16
31 Oct 201822.32%17.18
15 Nov 201822.82%15.2910-Q filed, results (8-K)
30 Nov 201823.44%15.65
14 Dec 201824.64%9.36
31 Dec 201828.51%12.15

See also: Medicines Company (The)'s full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.